|Print Page | Close Window|
|April 29, 2016 - 8:22 a.m.|
European CHMP Adopts Positive Opinion for Gilead’s TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for Treatment of HIV
|April 28, 2016 - 4:04 p.m.|
Gilead Sciences Announces Second Quarter 2016 Dividend
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.